99mTc-NDX-3315

N/A

Report date: 2025/11/20 20:00:05
NME

Base Information

Drug Name99mTc-NDX-3315
Drug Alias NameNDX-3315NDX33-099mTc-NDX-3315
ClassificationSmall molecules > Heterocyclic drugsDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agent +[5] 
Mechanisms of ActionDiagnostic imaging enhancersBone marrow proteoglycan modulators
TargetsBone marrow proteoglycan
Therapy Area/IndicationsEosinophilic Esophagitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNexEos Diagnostics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNexEos Diagnostics Inc
Inactive CompaniesN/A
Active IndicationsEosinophilic Esophagitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A